Document Detail


Effect of erythropoietin, 5-fluorouracil and SN-38 on the growth of DLD-1 cells.
MedLine Citation:
PMID:  21098876     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Supplementation of recombinant human erythropoietin (rHuEpo) is one of the methods for the treatment of anemia. The influence of rHuEpo on proliferation or clonogenic growth of cancer cells is not clear and some of the published results are conflicting. The aim of this work was to study the effect of rHuEpo on colon cancer cells when given alone or in combination with cytostatics. Human colon adenocarcinoma cells (DLD-1) were cultured in medium with rHuEpo, 5-fluorouracil (5-FU) and an active metabolite of irinotecan (SN-38). Cell viability was determined using a hematocytometer and 0.4% (w/v) trypan blue dye. Cell proliferation was measured by the MTT assay. Expression of EpoR, Bax, Bcl-2 and Akt1 protein was assessed by Western blot. The results of this study indicate a dose-dependent inhibitory effect of rHuEpo on DLD-1 cell growth and proliferation. Moreover, the combined treatment of rHuEpo and cytotoxic agents such as 5-FU and SN-38 increases the antitumor action, which is indicated by decreases in proliferation in the MTT test, cell numbers and DNA synthesis. We found a significant increase in EpoR, Bcl-2 and Akt1 protein expression in all cells grown in medium containing 3 IU of rHuEpo. We observed that EpoR is constitutively expressed in DLD-1 cells. Our results indicate that rHuEpo acts via EpoR to directly inhibit DLD-1 cell growth and indirectly modulate the cytostatics effects of 5-FU and SN-38.
Authors:
Anna Tankiewicz-Kwedlo; Dariusz Pawlak; Tomasz Domaniewski; Włodzimierz Buczko
Related Documents :
18363966 - Trps1 plays a pivotal role downstream of gdf5 signaling in promoting chondrogenesis and...
11930666 - Overexpression of bcl-2 protects hepatoma cell line hcc-9204 from ethanol-induced apopt...
20418896 - Cyclic bisbibenzyls induce growth arrest and apoptosis of human prostate cancer pc3 cells.
19507186 - Radiosensitization of ht-29 cells and xenografts by the nitric oxide donor detanonoate.
8371576 - Evidence that inositol phospholipids, but not choline phospholipids, are a potential so...
21311026 - Protein hydrolysate-induced cholecystokinin secretion from enteroendocrine cells is ind...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Pharmacological reports : PR     Volume:  62     ISSN:  1734-1140     ISO Abbreviation:  Pharmacol Rep     Publication Date:    2010 Sep-Oct
Date Detail:
Created Date:  2010-11-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101234999     Medline TA:  Pharmacol Rep     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  926-37     Citation Subset:  IM    
Affiliation:
Department of Pharmacodynamics, Medical University of Bialystok, Mickiewicza 2C, 15-222 Białystok, Poland. aniatan@poczta.onet.pl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Modulation of in vivo immunoglobulin production by endogenous histamine and H1R and H2R agonists and...
Next Document:  Family-based study of brain-derived neurotrophic factor (BDNF) gene polymorphism in alcohol dependen...